The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy

Clinical Immunology and Immunopathology

Volumn 78, Issue 2, 1996, Pages 120-129

  Adamus, Grazyna ^a   Aptsiauri, Nata ^b   Guy, John ^b   Heckenlively, John ^c   Flannery, John ^d   Hargrave, Paul A ^b  

^a RS Dow Neurological Sciences Institute   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c JULES STEIN EYE INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ENOLASE; IMMUNOGLOBULIN G1; RETINA ANTIGEN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; RETINOPATHY;

EID: 0029916703     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0021     Document Type: Article

References (26)

1. Sawyer, R. A., Selhorst, J. B., Zimmerman, L. E., and Hoyt, W. F., Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am. J. Ophthalmol. 81, 606-613, 1976.
2. Kornguth, S. E., Klein, R., Appen, R., and Choate, J., Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer 50, 1289-1293, 1982.
3. Grunwald, G. B., Simmonds, M. A., Klein, R., and Kornguth, S. E., Autoimmune basis for visual paraneoplastic syndrome in patients with small-cell lung carcinoma. Lancet March 23, 658-661, 1985.
4. Kornguth, S. E., Kalinke, T., Grunwald, G. B., Schutta, H., and Dahl, D., Anti-neurofilament antibodies in sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res. 46, 2588-2595, 1986.
5. Thirkill, C. E., Roth, A. M., and Keltner, J. L., Cancer-associated retinopathy. Arch. Ophthalmol. 105, 372-375, 1987.
6. Buchanan, T. A. S., Gardiner, T. A., and Archer, D. B., An ultrastructural study of retinal photoreceptor degeneration associated with bronchial carcinoma. Am. J. Ophthalmol. 97, 277-287, 1984.
7. Jacobson, D. M., Thirkill, C. E., and Tipping, S. J., A clinical triad to diagnose paraneoplastic retinopathy. Ann. Neurol. 28, 162-167, 1990.
8. Adamus, G., Guy, J., Schmied, J. L., Arendt, A., and Hargrave, P. A., Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Invest. Ophthalmol. Visual Sci. 34, 2626-2633, 1993.
9. Crofts, J. W., Bachynski, B. N., and Odel, J. G., Visual paraneoplastic syndrome associated with undifferentiated endometrial carcinoma. Can. J. Ophthalmol. 23, 128-132, 1988.
10. Campo, E., Brunier, M. N., and Merino, M. J., Small cell carcinoma of the endometrium with associated ocular paraneoplastic syndrome. Cancer 69, 2283-2288, 1992.
11. Klingele, T. G., Burde, R. M., Rappazzo, J. A., Isserman, M. J., Burgess, D., and Kantor, O., Paraneoplastic retinopathy. J. Clin. Neuro-ophthalmol. 4, 239-245, 1984.
12. Polans, A. S., Buczylko, J., Crabb, J., and Palczewski, K., A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J. Cell Biol. 112, 981-989, 1991.
13. Thirkill, C. E., FitzGerald, P., Sergott, R. C., Roth, A. M., Tyler, N. K., and Kaltner, J. L., Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. N. Engl. J. Med. 321, 1589-1594, 1989.
14. Rizzo, J. F., and Gittinger, J. W., Selective immunochemical staining in the paraneoplastic retinopathy syndrome. Ophthalmology 99, 1286-1295, 1992.
15. Laemmli, U. K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-688, 1970.
16. Hochstrasser, D. F., Harrington, M. G., Hochstrasser, A.-C., Miller, M. J., and Merril, C. R., Methods for increasing the resolution for two-dimensional protein electrophoresis. Anal. Biochem. 173, 424-435, 1988.
17. Schagger, H., and Van Jagow, G., Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166, 368-379, 1987.
18. McAleese, S. M., Dunbar, B., Fothergill, J. E., Hinks, L. J., and Day, I. N. M., Complete amino acid sequence of the neurone-specific gamma isozyme of enolase from human brain and comparison with the non-neuronal alpha form. Eur. J. Biochem. 178, 413-417, 1988.
19. Shimizu, A., Suzuki, F., and Kato, K., Characterization of αα, ββ, γγ and αγ human enolase isoenzymes, and preparation of hybrid enolases (αγ and αβ) from homodimeric forms. Biochim. Biophys. Acta 748, 278-284, 1983.
20. Ishiguro, Y., Kato, K., Shimizu, A., Ito, T., and Nagaya, M., High level of immunoreactive nervous system-specific enolase in sera of patients with neuroblastoma. Clin. Chim. Acta 121, 173-180, 1982.
21. Schmechel, D., Marangos, P. J., Brightman, M., and Goodwin, F. K., Brain enolases as specific markers of neuronal and glial cells. Science 199, 313-315, 1978.
22. Johnson, D. H., Marangos, P. J., Forbes, J. T., Hainsworth, J. D., VanWelch, R., Hande, K. R., and Greco, F. A., Potential utility of serum neuron-specific enolase levels in small cell carcinoma of the lung. Cancer Res. 44, 5409-5414, 1984.
23. Carney, D. N., Ihde, D. C., Cohen, M. H., Marangos, P. J., Bunn, P. A., Jr. , Minna, J. D., and Gazdar, A. F., Serum neuron-specific enolase: A marker for disease extent and response to therapy of small-cell lung cancer. Lancet 1, 583-585, 1982.
24. Gomm, S. A., Keevil, B. G., Thatcher, N., Hasleton, P. S., and Swindell, R. S., The value of tumour markers in lung cancer. Br. J. Cancer 58, 797-804, 1988.
25. Akoun, G. M., Scarna, H. M., Milleron, B. J., Benichou, M. P., and Herman, D. P., Serum neuron-specific enolase: A marker for disease extent and response to therapy for small-cell lung cancer. Chest 87, 39-43, 1985.
26. Polans, A., Witkowska, D., Haley, T., Amundson, D., Baizer, L., and Adamus, G., Recoverin, a photoreceptor-specific calciumbinding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Proc. Natl. Acad. Sci. USA 92, 9176-9180, 1995.